Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Pulmonx
LUNG
$104M
| $1.38M | ﹤0.01% |
204,818
+55,716
| +37% | +$394K |
|
1602
PUT
Blue Owl Capital
OWL
$18.1B
| $1.37M | ﹤0.01% |
68,500
+22,900
| +50% | +$515K |
|
1603
CALL
CarMax
KMX
$9B
| $1.37M | ﹤0.01% |
17,600
-2,700
| -13% | -$216K |
|
1604
PUT
Analog Devices
ADI
$179B
| $1.37M | ﹤0.01% |
6,800
+1,900
| +39% | +$411K |
|
1605
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
| $1.35M | ﹤0.01% |
16,590
-63,235
| -79% | -$5.05M |
|
1606
CryoPort
CYRX
$844M
| $1.35M | ﹤0.01% |
222,389
+62,610
| +39% | +$433K |
|
|
1607
CALL
Analog Devices
ADI
$179B
| $1.35M | ﹤0.01% |
6,700
-14,800
| -69% | -$3.2M |
|
1608
CALL
PVH
PVH
$3.47B
| $1.35M | ﹤0.01% |
20,900
+16,300
| +354% | +$1.32M |
|
1609
PUT
PayPal
PYPL
$53B
| $1.35M | ﹤0.01% |
20,700
+9,900
| +92% | +$771K |
|
|
RDUS
1610
DELISTED
Radius Recycling
RDUS
| $1.35M | ﹤0.01% |
46,741
+17,110
| +58% | +$276K |
|
|
EUAD
1611
Select STOXX Europe Aerospace & Defense ETF
EUAD
$1.19B
| $1.34M | ﹤0.01% |
+40,000
| New | +$1.18M |
|
1612
PUT
Clorox
CLX
$12.8B
| $1.34M | ﹤0.01% |
9,100
-9,800
| -52% | -$1.5M |
|
1613
Schwab US Large- Cap ETF
SCHX
$73.8B
| $1.34M | ﹤0.01% |
60,580
-44,097
| -42% | -$1.03M |
|
1614
PUT
Centrus Energy
LEU
$3.64B
| $1.34M | ﹤0.01% |
21,500
+3,600
| +20% | +$303K |
|
1615
PUT
FIVE9
FIVN
$2.43B
| $1.34M | ﹤0.01% |
49,200
| – | – |
|
1616
iShares MSCI China ETF
MCHI
$6.23B
| $1.33M | ﹤0.01% |
24,530
-52,195
| -68% | -$2.69M |
|
1617
First Majestic Silver
AG
$10.3B
| $1.33M | ﹤0.01% |
+199,436
| New | +$1.19M |
|
1618
Clearway Energy Class C
CWEN
$6.71B
| $1.33M | ﹤0.01% |
44,035
-24,533
| -36% | -$667K |
|
1619
PUT
Freeport-McMoran
FCX
$113B
| $1.33M | ﹤0.01% |
35,200
+12,300
| +54% | +$471K |
|
1620
CALL
Lowe's Companies
LOW
$120B
| $1.33M | ﹤0.01% |
5,700
-40,500
| -88% | -$9.97M |
|
1621
Tiptree Inc
TIPT
$682M
| $1.32M | ﹤0.01% |
+55,000
| New | +$1.17M |
|
1622
PUT
T. Rowe Price
TROW
$23.8B
| $1.32M | ﹤0.01% |
14,400
+9,100
| +172% | +$962K |
|
1623
PUT
PNC Financial Services
PNC
$97B
| $1.32M | ﹤0.01% |
7,500
+5,200
| +226% | +$982K |
|
1624
CALL
Synchrony
SYF
$25.9B
| $1.32M | ﹤0.01% |
24,900
-17,500
| -41% | -$1.08M |
|
|
HDV
1625
iShares Core High Dividend ETF
HDV
$15.4B
| $1.32M | ﹤0.01% |
54,415
-138,890
| -72% | -$3.25M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.